Patents by Inventor Sanjeev Mahanta

Sanjeev Mahanta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230295340
    Abstract: The present describes monoclonal antibodies.
    Type: Application
    Filed: December 6, 2022
    Publication date: September 21, 2023
    Inventors: Cynthia Bamdad, Sanjeev Mahanta
  • Patent number: 11560435
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: January 24, 2023
    Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia Bamdad, Sanjeev Mahanta
  • Publication number: 20200239594
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Application
    Filed: August 13, 2019
    Publication date: July 30, 2020
    Applicant: Minerva Biotechnologies Corporation
    Inventors: Cynthia Bamdad, Sanjeev Mahanta
  • Patent number: 10421819
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: September 24, 2019
    Assignee: Minerva Biotechnologies Corporation
    Inventors: Cynthia C. Bamdad, Sanjeev Mahanta
  • Publication number: 20180222998
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Application
    Filed: October 6, 2009
    Publication date: August 9, 2018
    Applicant: MINERVA BIOTECHNOLOGIES CORPORATION
    Inventors: Cynthia C. BAMDAD, Sanjeev MAHANTA
  • Publication number: 20170204191
    Abstract: The present describes monoclonal antibody to MUC1*.
    Type: Application
    Filed: October 6, 2009
    Publication date: July 20, 2017
    Inventors: Cynthia C. BAMDAD, Sanjeev Mahanta